Combination therapy in the management of mixed dyslipidaemia

Journal of Internal Medicine

Volumn 263, Issue 4, 2008, Pages 353-365

  Cannon, C P ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Combination therapy; Dyslipidaemia; Fenofibrate; Niacin; Statin

Indexed keywords

ATORVASTATIN; BEZAFIBRATE; COLESTIPOL; EZETIMIBE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LAROPIPRANT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; PRAVASTATIN; PROSTAGLANDIN INHIBITOR; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; BLEEDING TIME; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DYSLIPIDEMIA; FLUSHING; GASTROINTESTINAL SYMPTOM; GLUCURONIDATION; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; METABOLIC SYNDROME X; MONOTHERAPY; MYOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; RHABDOMYOLYSIS; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL;

ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION ROUTES; DRUG THERAPY, COMBINATION; DYSLIPIDEMIAS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; NIACIN; PROCETOFEN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 40349093031     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01933.x     Document Type: Review

References (88)